Ghent University Academic Bibliography

Your filters: cql: author="Dougados, Maxime" or (type any "bookEditor issueEditor" and editor="Dougados, Maxime")

Add to list
- Journal Article
- A1
- open access
Prevalence and incidence of uveitis in patients with spondyloarthritis : the impact of the biologics era : data from the international ASAS-COMOSPA study

Hernan Maldonado-Ficco, Clementina Lopez-Medina, Rodolfo Perez-Alamino, Christian A. Waimann, Jose A. Maldonado-Cocco, Anna Molto, Maxime Dougados, Robert B. M. Landewe, Desiree van der Heijde and Filip Van den Bosch (UGent)

(2025) RHEUMATOLOGY. 64(5). p.2618-2624
Add to list
- Journal Article
- A1
- open access
Trends to shorter diagnostic delay in spondyloarthritis patients during the last decades and association with clinical presentation : data from ASAS-COMOSPA study

Rodolfo Perez-Alamino, Hernan Maldonado-Ficco, Anna Molto, Christian Waimann, Jose Maldonado-Cocco, Maxime Dougados, Robert Landewe, Desiree van der Heijde, Filip Van den Bosch (UGent) , Gaëlle Varkas (UGent) , et al.

(2025) RMD OPEN. 11(1).
Add to list
- Journal Article
- A1
- open access
The assessment of SpondyloArthritis International Society (ASAS) consensus-based expert definition of difficult-to-manage, including treatment-refractory, axial spondyloarthritis

Denis Poddubnyy, Victoria Navarro-Compan, Murat Torgutalp, Suzanne Arends, Sibel Zehra Aydin, Simone Battista, Filip Van den Bosch (UGent) , Christine Bundy, Alberto Cauli, Jo Davies, et al.

(2025) ANNALS OF THE RHEUMATIC DISEASES. 84(4). p.538-546
Add to list
Sacroiliac radiographic progression over 10 years in axSpA : data from the DESIR inception cohort

Anna Molto, Clementina Lopez-Medina, Alexandre Sepriano, Sofia Ramiro, Manouk de Hooge (UGent) , Miranda van Lunteren, Victoria Navarro-Compan, Daniel Wendling and Maxime Dougados

(2024) ANNALS OF THE RHEUMATIC DISEASES. 83(7). p.858-864
Add to list
- Journal Article
- A1
- open access
Response to : 'Correspondence on 'Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis : results of the open-label, pragmatic, cluster-randomised TICOSPA trial' by Cai and Peng response

Anna Molto, Desiree van der Heijde, Filip Van den Bosch (UGent) and Maxime Dougados

(2023) ANNALS OF THE RHEUMATIC DISEASES. 82(7).
Add to list
- Miscellaneous
- open access
Goodbye to the term ‘ankylosing spondylitis’, hello ‘axial spondyloarthritis’ : time to embrace the ASAS-defined nomenclature

Désirée van der Heijde, Anna Molto, Sofia Ramiro, Jürgen Braun, Maxime Dougados, Floris A van Gaalen, Lianne S Gensler, Robert D Inman, Robert B M Landewé, Helena Marzo-Ortega, et al.

(2023) ANNALS OF THE RHEUMATIC DISEASES. 83(5). p.547-549
Add to list
- Journal Article
- A1
- open access
Structural changes in the sacroiliac joint on MRI and relationship to ASDAS inactive disease in axial spondyloarthritis : a 2-year study comparing treatment with etanercept in EMBARK to a contemporary control cohort in DESIR

Walter P. Maksymowych, Pascal Claudepierre, Manouk de Hooge (UGent) , Robert G. Lambert, Robert Landewé, Anna Molto, Désirée van der Heijde, Jack F. Bukowski, Heather Jones, Ron Pedersen, et al.

(2021) ARTHRITIS RESEARCH & THERAPY. 23(1).
Add to list
- Journal Article
- A1
- open access
Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis : results of the open-label, pragmatic, cluster-randomised TICOSPA trial

Anna Molto, Clementina López-Medina, Filip Van den Bosch (UGent) , Annelies Boonen, Casper Webers, Emanuelle Dernis, Floris A van Gaalen, Martin Soubrier, Pascal Claudepierre, Athan Baillet, et al.

(2021) ANNALS OF THE RHEUMATIC DISEASES. 80(11). p.1436-1444
Add to list
- Journal Article
- A1
- open access
Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors : a consensus statement

Peter Nash, Andreas Kerschbaumer, Thomas Doerner, Maxime Dougados, Roy M. Fleischmann, Klaus Geissler, Iain McInnes, Janet E. Pope, Desiree van der Heijde, Michaela Stoffer-Marx, et al.

(2021) ANNALS OF THE RHEUMATIC DISEASES. 80(1). p.71-87
Add to list
- Journal Article
- A1
- open access
Association between administration of IL-6 antagonists and mortality among patients hospitalized for COVID-19 : a meta-analysis

[missing] The WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group, Pere Domingo, Isabel Mur, Gracia María Mateo, Maria del Mar Gutierrez, Virginia Pomar, Natividad de Benito, Noemí Corbacho, Silvia Herrera, Lucia Millan, et al.

(2021) JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. 326(6). p.499-518

Academic Bibliography

Prevalence and incidence of uveitis in patients with spondyloarthritis : the impact of the biologics era : data from the international ASAS-COMOSPA study

Trends to shorter diagnostic delay in spondyloarthritis patients during the last decades and association with clinical presentation : data from ASAS-COMOSPA study

The assessment of SpondyloArthritis International Society (ASAS) consensus-based expert definition of difficult-to-manage, including treatment-refractory, axial spondyloarthritis

Sacroiliac radiographic progression over 10 years in axSpA : data from the DESIR inception cohort

Response to : 'Correspondence on 'Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis : results of the open-label, pragmatic, cluster-randomised TICOSPA trial' by Cai and Peng response

Goodbye to the term ‘ankylosing spondylitis’, hello ‘axial spondyloarthritis’ : time to embrace the ASAS-defined nomenclature

Structural changes in the sacroiliac joint on MRI and relationship to ASDAS inactive disease in axial spondyloarthritis : a 2-year study comparing treatment with etanercept in EMBARK to a contemporary control cohort in DESIR

Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis : results of the open-label, pragmatic, cluster-randomised TICOSPA trial

Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors : a consensus statement

Association between administration of IL-6 antagonists and mortality among patients hospitalized for COVID-19 : a meta-analysis

Contents

Support

Contact